Better Overview
Better specializes in developing medical-grade cannabis for a variety of medical conditions. The companys strains are developed with diverse CBD and THC combinations and high terpene levels in order to increase the efficiency and potency of its products for medical use. The company offers a range of products designed to address the particular medical needs of its clients. Betters medical-grade cannabis is a standardized and stable natural medicine grown by experts with many years of experience. Its contaminant-free product is guaranteed to contain a consistent level of active pharmaceutical ingredients, including THC, CBD, and other cannabinoids. The company has developed eight unique strains with more in development. Betters strain diversity enables it to cover a wide range of conditions, and the strains offer an extensive variety of cannabinoid and terpene combinations, resulting in a plethora of smells, flavors, colors, and medicinal effects.
Cumulative Funding Raised Over Time ($)
$15.0MDec 2019
Latest News
growth-positive
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer "Better"
InterCure Ltd. has announced its acquisition of Cann Pharmaceutical Ltd. (Better), a medical cannabis multi-national operator. The acquisition is expected to strengthen InterCures position as the largest cannabis company outside of North America and expand its global reach. Betters unique strains and high-quality products will complement InterCures portfolio. The acquisition is expected to be accretive and create immediate value. The purchase price is USD 35 million, paid with InterCure shares at a valuation of USD 10 per share. The acquisition is subject to customary closing conditions and approvals. The transaction is expected to close in Q3 2022. InterCure is a leading cannabis company, while Better is a pharmaceutical-grade medical cannabis company known for its cultivation, marketing, and research expertise. The acquisition is a significant milestone in the cannabis industry and will accelerate InterCures global expansion plans.
Acquisition
growth-positive
Subversive Acquisition LP Announces InterCure's Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings
InterCure Ltd. has signed a Letter of Intent to acquire Better Holdings, a medical cannabis operator in Israel and Australia. The acquisition strengthens InterCures position as the largest cannabis company outside of North America and expands its global reach. The companies expect to sign detailed and binding agreements within 90 days. The total consideration for the acquisition is USD $35 million, payable with InterCure shares. InterCure will also invest up to USD $2.5 million in Better Australia. The transaction is expected to enhance InterCures portfolio, distribution network, and partnerships.
Acquisition
growth-positive
חברת הקנאביס שכמעט התפרקה ועוזרת היום לילדים עם אוטיזם
בטר, an Israeli medical cannabis company, has raised $15 million from Thai investor Narin Niaotianon, in exchange for 32% of the company. The funds will enable the company to resume plans that were previously halted due to lack of budget, such as conducting comprehensive clinical trials on its products for epilepsy and autism, and expanding its operations in Australia. The companys CEO, Yaakov (Kobi) Molcho, took over after the departure of the previous management. בטר is also developing a specific product for autism, which already has a strong lobby of Israeli parents who swear by the product.
InvestmentManagement Changes
growth-positive
Thai businessman Narin Niruttinanon is the mysterious investor in Israeli cannabis company Better
Better Holdings, an Israeli cannabis company, has requested approval from Israels Ministry of Health for Narin Niruttinanon to become a controlling stakeholder in exchange for a $15 million investment. Better Holdings recently submitted a request to approve Niruttinanon as a controlling stakeholder, and he is set to invest $15 million for a 32% stake in the company. The deal values Better Holdings at $46.8 million, and the remaining 36% of the companys shares will stay with existing stakeholders. Niruttinanon is a real estate investor and the owner of Reading Football Club. Better Holdings hopes that the investment will help the company overcome its difficulties and promote clinical research for regulatory approval and a potential IPO in the future.
Investment
growth-negative
Cannabis Company Better Holdings Wants to Sell Israeli Operations
Better Holdings, a medical cannabis company in Israel, is offering to sell its Israeli operations for NIS 20 million. The companys main point of interest is its stock of quality cannabis strains. Better used to be the second largest medical cannabis company in Israel but has faced trouble due to the countrys recent cannabis reform and the need to reissue its permanent license under new regulations. Better also operates in Australia with a farm, medical cannabis export and import licenses, and a clinical trial for epilepsy treatment.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $15M |
| Last funding | $15M |
| Stage | Mature |
| Rounds | 1 |
| Investors | 1 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | www.better-global.com/en/home |
Locations
HaYarkon Street 288, Tel Aviv-Yafo, Israel
Photos & Videos
No files yet
Better Business
Business models
B2B, B2B2C
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisTarget Customer
Healthcare & Life SciencesHealthcarePatientsCore Technology
BiologicalsHerbalsTags (7)
biotechnologybreedingcannabispharmaceuticalsmedical-technologiespain-reliefautismGeographic Markets
AustraliaGlobalBetter Financials
$15M
Total funding
Undisclosed
Capital raised
$15M
Last funding
Mature
Funding stage
1
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$15.0MDec 2019
Private Equity Funding
Undisclosed Round
Dec 2019
$15M
Narin Niruttinanon
Better Lifecycle
Cumulative Funding Raised Over Time
$15.0MDec 2019
All Events
Undisclosed Round
Dec 2019
$15M
Narin Niruttinanon
Better News
8 articles
growth-positive
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer "Better"
InterCure Ltd. has announced its acquisition of Cann Pharmaceutical Ltd. (Better), a medical cannabis multi-national operator. The acquisition is expected to strengthen InterCures position as the largest cannabis company outside of North America and expand its global reach. Betters unique strains and high-quality products will complement InterCures portfolio. The acquisition is expected to be accretive and create immediate value. The purchase price is USD 35 million, paid with InterCure shares at a valuation of USD 10 per share. The acquisition is subject to customary closing conditions and approvals. The transaction is expected to close in Q3 2022. InterCure is a leading cannabis company, while Better is a pharmaceutical-grade medical cannabis company known for its cultivation, marketing, and research expertise. The acquisition is a significant milestone in the cannabis industry and will accelerate InterCures global expansion plans.
Acquisition
growth-positive
Subversive Acquisition LP Announces InterCure's Letter of Intent Relating to the Acquisition of a Multi-National Medical Cannabis Producer, Better Holdings
InterCure Ltd. has signed a Letter of Intent to acquire Better Holdings, a medical cannabis operator in Israel and Australia. The acquisition strengthens InterCures position as the largest cannabis company outside of North America and expands its global reach. The companies expect to sign detailed and binding agreements within 90 days. The total consideration for the acquisition is USD $35 million, payable with InterCure shares. InterCure will also invest up to USD $2.5 million in Better Australia. The transaction is expected to enhance InterCures portfolio, distribution network, and partnerships.
Acquisition
growth-positive
חברת הקנאביס שכמעט התפרקה ועוזרת היום לילדים עם אוטיזם
בטר, an Israeli medical cannabis company, has raised $15 million from Thai investor Narin Niaotianon, in exchange for 32% of the company. The funds will enable the company to resume plans that were previously halted due to lack of budget, such as conducting comprehensive clinical trials on its products for epilepsy and autism, and expanding its operations in Australia. The companys CEO, Yaakov (Kobi) Molcho, took over after the departure of the previous management. בטר is also developing a specific product for autism, which already has a strong lobby of Israeli parents who swear by the product.
InvestmentManagement Changes
growth-positive
Thai businessman Narin Niruttinanon is the mysterious investor in Israeli cannabis company Better
Better Holdings, an Israeli cannabis company, has requested approval from Israels Ministry of Health for Narin Niruttinanon to become a controlling stakeholder in exchange for a $15 million investment. Better Holdings recently submitted a request to approve Niruttinanon as a controlling stakeholder, and he is set to invest $15 million for a 32% stake in the company. The deal values Better Holdings at $46.8 million, and the remaining 36% of the companys shares will stay with existing stakeholders. Niruttinanon is a real estate investor and the owner of Reading Football Club. Better Holdings hopes that the investment will help the company overcome its difficulties and promote clinical research for regulatory approval and a potential IPO in the future.
Investment
growth-negative
Cannabis Company Better Holdings Wants to Sell Israeli Operations
Better Holdings, a medical cannabis company in Israel, is offering to sell its Israeli operations for NIS 20 million. The companys main point of interest is its stock of quality cannabis strains. Better used to be the second largest medical cannabis company in Israel but has faced trouble due to the countrys recent cannabis reform and the need to reissue its permanent license under new regulations. Better also operates in Australia with a farm, medical cannabis export and import licenses, and a clinical trial for epilepsy treatment.
Customers
Growth-negative
350 קילו של קנאביס נגנבו מחוות חברת בטר
Better Cannabis, one of the largest and most profitable cannabis companies in Israel, recently suffered a theft of 350 kilograms of cannabis, estimated to be worth around 1.5 million shekels. The company has downplayed the incident, stating that the loss is not dramatic in relation to the companys operations. The company was recently supposed to merge with Whitesmoke, but the merger was cancelled. There is interest from the tech and gaming world to invest in the company, including from tech entrepreneur Gigi Levy-Weiss.
Management Changes
growth-positive
Better Founder Yohai Gild Golan and Israel Are Advancing Medicinal Marijuana Research for All
Better, a medical-grade cannabis company founded by Yohai Gild Golan, has been advancing medicinal marijuana research in Israel. The Israeli governments support for medicinal marijuana use has allowed Better to conduct medical research and develop specific medical strains that can treat different ailments. Better played a key role in establishing Israels federally-approved medical marijuana program and has helped build the entire cannabis program from scratch. After almost a decade of research, Better is now preparing to share its findings with lawmakers and doctors worldwide. The companys focus is on developing and providing treatment-specific cannabis strains to those in need.
CustomersPartners
growth-positive
Medical cannabis to be trialled in treatment of melanoma at the University of Canberra
The University of Canberra has signed a million-dollar deal with Cann Pharmaceutical Australia to develop a new treatment for skin cancer using medicinal-grade cannabis. The two-year research project, led by Professor Sudha Rao, aims to create an immunotherapy treatment to complement traditional chemotherapy. Clinical trials will begin in the ACT next year, and the first results could be known within nine months. The hope is to create a treatment that will assist and boost the immune system for melanoma and other cancer patients. The medicinal cannabis used in the trials is a specialist strain grown in Israel. This research may also have implications for the legality of medicinal cannabis in Australia.
PartnersInvestment
Better Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 11 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 8 classification IDs that could be used for matching.
Better Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | video or image, markets |
| BI Verification | Natalia Golczar |
| Registrar ID | 514304427 |
| Crunchbase | cann-pharmaceutical-better |
| Phone | +97236355101, +97236355101 |
| Creator | Fredrik Liljedahl |
| Creator email | fredrik.liljedahl@sncentral.org |
| Last updater | Jenny Sotnik-Talisman |
| Updater email | genys30@yahoo.com |
| Last update | 2022-07-19T00:00:00.000Z |
| Created | 2017-05-09T00:00:00.000Z |
| Claimed | Yes |